Streamline Health® To Report Third Quarter 2022 Financial Performance and Provide Corporate Update
07 déc. 2022 16h30 HE
|
Streamline Health Solutions, Inc.
Atlanta, GA, Dec. 07, 2022 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. (“Streamline” or the “Company”) (Nasdaq: STRM), a leading provider of solutions that enable healthcare providers to...
Denarius Metals Announces Third Quarter and First Nine Months 2022 Results
28 nov. 2022 07h00 HE
|
Denarius Metals Corp.
TORONTO, Nov. 28, 2022 (GLOBE NEWSWIRE) -- Denarius Metals Corp. (“Denarius Metals” or “the Company”) (TSXV: DSLV; OTCQB: DNRSF) announced today that it has filed its unaudited interim condensed...
Viewbix Reports Third Quarter 2022 Financial Results with a 176% Growth in Revenues Totaling $66 Million
22 nov. 2022 16h10 HE
|
Viewbix Inc.
Viewbix reached an operating income of $1.4 million Amihay Hadad, Viewbix, CEO: “We entered the field of digital content through apurchase that has proven itself, financially and synergistic and it...
Aridis Pharmaceuticals Announces Third Quarter 2022 Financial Results and Business Update
21 nov. 2022 18h30 HE
|
Aridis Pharmaceuticals, Inc.
Top-line data from the Phase 3 clinical trial evaluating AR-301 for the treatment of VAP expected in December of this year LOS GATOS, Calif., Nov. 21, 2022 (GLOBE NEWSWIRE) -- Aridis...
RYVYL Reports Third Quarter 2022 Financial Results
21 nov. 2022 16h15 HE
|
RYVYL Inc.
Third Quarter 2022 Highlighted by Strong Processing Volume Growth, Company Rebranding and Launch of coyni Platform SAN DIEGO, CA, Nov. 21, 2022 (GLOBE NEWSWIRE) -- RYVYL Inc. (NASDAQ: RVYL)...
BioStem Technologies Reports Third Quarter 2022 Operating and Financial Results
15 nov. 2022 16h05 HE
|
BioStem Technologies, Inc.
Company to Host a Conference Call and Webcast on November 15, 2022, at 4:30 pm EDT POMPANO BEACH, FLORIDA., Nov. 15, 2022 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading...
QSAM Biosciences Reports Third Quarter 2022 Financial Results and Provides Corporate Update
15 nov. 2022 08h00 HE
|
QSAM Biosciences Inc.
Further Progress Demonstrated in Clinical Program Evaluating CycloSam® Radiopharmaceutical Drug Candidate for Treatment of Metastatic Bone Cancer AUSTIN, Texas, Nov. 15, 2022 (GLOBE...
Qualigen Therapeutics, Inc. Reports Third Quarter 2022 Financial Results and Provides Corporate Update
15 nov. 2022 07h30 HE
|
Qualigen Therapeutics, Inc.
Q3 2022 FastPack ® sales increased approximately 25% year-over-yearCompany continues to execute on and advance core therapeutic programs CARLSBAD, Calif., Nov. 15, 2022 (GLOBE NEWSWIRE) -- Qualigen...
OMNIQ REPORTS RECORD REVENUE OF $27M FOR Q3 2022 UP 32% OVER Q3 2021 AND RECORD 9 MONTH REVENUE OF $77.5M UP 45% OVER SAME PERIOD OF 2021. - Updated
14 nov. 2022 17h54 HE
|
OMNIQ Corp.
SALT LAKE CITY, Nov. 14, 2022 (GLOBE NEWSWIRE) -- OMNIQ Corp. (NASDAQ: OMQS) (“OMNIQ” or “the Company”), a provider of Supply Chain and Artificial Intelligence (AI)-based solutions, today announced...
Interpace Biosciences Announces Third Quarter 2022 Financial and Business Results Sale of Pharma Significantly Improves Liquidity Resulting in Removal of Going Concern
14 nov. 2022 16h41 HE
|
Interpace Biosciences, Inc.
Q3 Revenue of $8.2 million up 2% versus Prior YearQ3 Adjusted EBITDA PositiveCash and Cash Equivalents total $6.3 million as of September 30, 2022 PARSIPPANY, NJ, Nov. 14, 2022 (GLOBE NEWSWIRE)...